New leadership for Agfa's Germany, Austria and Switzerland operations announced

TriMed Staff | | Health Imaging | Artificial Intelligence
Agfa has appointed Thomas Pasold as country manager with responsibility of leading its healthcare operations for the combined market of Germany, Austria and Switzerland. Before joining Agfa in February 2005, Pasold was sales & marketing director at Torex GAP. Pasold has over 20 years of experience in healthcare IT. He will report to Paul Veithen, General Manager Agfa Europe.

Also, Michael Wagemann has been assigned leadership of the Imaging business unit in Germany, Austria and Switzerland with its more than 120 employees. According to Agfa, the Imaging business unit is vitally important because of its size and business value. Wagemann will report directly to Thomas Pasold.

TriMed Staff

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.